The development of chronic myelogenous leukemia tumor-resistance to Gleevec appears to be a common occurence. What is presently thought to be the best drug regimen for treating chronic myelogenous leukemia?

Question

Quizplus · Accepted Answer

A cocktail of several different inhibitors that target different parts of the Abl protein is presently thought to be the best drug regimen for treating chronic myelogenous leukemia. This approach helps to avoid the development of resistance to a single drug by targeting multiple sites on the Abl protein, which reduces the likelihood that cancer cells will develop mutations that enable them to overcome the effects of the drugs.

The Development of Chronic Myelogenous Leukemia Tumor-Resistance to Gleevec Appears